ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $0 | – | 261 | -1.5% | 0.00% | – |
Q2 2021 | $0 | – | 265 | 0.0% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 265 | -98.6% | 0.00% | -100.0% |
Q3 2020 | $29,000 | +20.8% | 19,507 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $24,000 | -4.0% | 19,507 | -7.6% | 0.00% | 0.0% |
Q1 2020 | $25,000 | +316.7% | 21,112 | +607.3% | 0.00% | – |
Q4 2019 | $6,000 | -14.3% | 2,985 | -6.6% | 0.00% | – |
Q3 2019 | $7,000 | -36.4% | 3,197 | -24.3% | 0.00% | -100.0% |
Q2 2019 | $11,000 | +120.0% | 4,221 | +220.3% | 0.00% | – |
Q1 2019 | $5,000 | +66.7% | 1,318 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -84.2% | 1,318 | -73.4% | 0.00% | -100.0% |
Q3 2018 | $19,000 | -99.6% | 4,959 | +281.5% | 0.00% | – |
Q2 2018 | $4,388,000 | +146166.7% | 1,300 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | -40.0% | 1,300 | +16.1% | 0.00% | -100.0% |
Q3 2017 | $5,000 | +25.0% | 1,120 | -33.1% | 0.00% | – |
Q2 2017 | $4,000 | -20.0% | 1,673 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | -68.8% | 1,673 | -73.5% | 0.00% | -100.0% |
Q4 2016 | $16,000 | – | 6,319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |